Brain connectivity changes in glioma patients during treatment
Official title: Functional Reorganization and Connectivity in Glioma Patients During the Therapeutic Trajectory
Run by Johannes Kepler University of Linz · NCT07612917 · Data updated 2026-11-12
Researchers will observe how glioma treatment affects brain connectivity and function using repeated MRI to see if brain areas and their connections adapt over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Johannes Kepler University of Linz Academic / other |
| Locations | 1 site (Linz, Upper Austria) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | September 2029 |
| Study ends | December 2029 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT07612917 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-64 with diffuse gliomas (WHO grade 2-4) who can undergo baseline and follow-up fMRI and neurocognitive testing with informed consent.
✕Probably not a fit
Patients who cannot complete serial MRI or neurocognitive assessments, or who have contraindications to MRI, may not benefit from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study involving adults with diffuse gliomas (WHO grades 2-4) who undergo repeated functional MRI and neurocognitive assessments as part of their care. The goal is to map how key brain regions and their white matter connections reorganize during treatment, shedding light on neuroplasticity in the context of glioma therapy. Imaging and cognitive data will be analyzed over the course of treatment to identify patterns of change and potential predictors of adaptation. No experimental interventions are described; the study relies on standard imaging and assessments available to participants. Results may inform understanding of brain resilience and guide future patient management.
Why it matters
Potential benefit: Findings could help clinicians anticipate brain changes during treatment and tailor supportive care to preserve function.
How similar studies have gone: Prior imaging studies in glioma have shown brain network changes during treatment, supporting feasibility of this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with diffuse gliomas (WHO grade 2-4). * Age \>18 years and \<65 years. * Written participant information and informed consent provided and signed. * Signed informed consent for functional magnetic resonance imaging (fMRI). Exclusion Criteria: * Age \<18 years or \>65 years. * Pregnancy. * Contraindications to MRI, including but not limited to: * Active medical implants (e.g., pain pump, defibrillator, cardiac pacemaker), * Orthodontic braces, * Metallic tattoos, * Non-removable piercings, * Known metallic foreign bodies, * Claustrophobia. * Cerebral metastases from secondary (non-primary) tumors. * Absence of baseline BOLD functional MRI and/or baseline neurocognitive assessment. * Failure to provide written participant information and informed consent. * Karnofsky Performance Status (KPS) \<60, unless feasibility of clinical-psychological testing and BOLD fMRI is confirmed by the investigator in consultation with clinical psychology, radiology staff, and the patient.
Where it's running
-
Kepler University Hospital
Linz, Upper Austria, Austria Recruiting
Study contacts
- Principal investigator: Michael Sonnberger, MD — Head of Institute of Neuroradiology, Kepler University Hospital Linz, Johannes Kepler University
- Study coordinator: Raimund Kleiser, PD Dr.
- Email: raimund.kleiser@kepleruniklinikum.at
- Phone: +43 5 7680 87 - 26701
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain connectome project in adults with brain glioma undergoing surgery
This registry collects MRI data and clinical information from adults with glioma to see how brain networks relate to surgery and recovery.
-
Can a phone version of the Mini-Cog identify cognitive impairment before surgery?
This study tests whether a telephone-based Mini-Cog can reliably detect cognitive impairment in adults 65 and older before they have surgery.
-
Personalized TMS to Test Heart-Brain Linking in People with Depressive Tendencies
This study tests whether individualized TMS guided by each person’s brain connections can influence heart-brain coupling in adults with depressive symptoms.
-
How different eTNS frequencies affect brain activity and autonomic function in healthy volunteers
This study tests whether two frequencies of transcutaneous trigeminal nerve stimulation (2 Hz and 120 Hz) change brain activity and autonomic signals compared with a sham in healthy adults.
-
Testing how eTNS affects the brain: is it skin nerves or direct skull stimulation driving the effect?
This study tests whether transcutaneous trigeminal nerve stimulation works mainly through skin nerves or by currents reaching the brain, in healthy volunteers using fMRI.
-
At-home ear vagus nerve stimulation plus computer brain training for thinking and mood
This study will try at-home transcutaneous auricular vagus nerve stimulation combined with computerized cognitive training to see if it helps people aged 45-80 with self-reported cognitive changes improve thinking and mood.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.